Cowen Starts Sophia Genetics SA (SOPH) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
UPDATE: Credit Suisse Starts Sophia Genetics SA (SOPH) at Outperform
August 17, 2021 4:27 AM EDT(Updated - August 17, 2021 4:43 AM EDT)
Credit Suisse analyst Katie Tryhane initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Outperform rating and a price target of $22.00.
The analyst comments "SOPH is a healthcare technology company offering a decentralized software platform that leverages... More
JPMorgan Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 4:20 AM EDTJPMorgan analyst Tycho W. Peterson initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on Sophia Genetics SA... More
UPDATE: Morgan Stanley Starts Sophia Genetics SA (SOPH) at Overweight
August 17, 2021 3:31 AM EDT(Updated - August 17, 2021 4:41 AM EDT)
Morgan Stanley analyst Tejas Savant initiates coverage on Sophia Genetics SA (NASDAQ: SOPH) with a Overweight rating and a price target of $24.00.
The analyst comments "Riding on the coattails of healthcare digitization, SOPHs differentiated... More
